Lyumjev – A New Insulin Lispro for Diabetes
Date: October 19, 2020 Issue #: 1609 Summary: The FDA has approved insulin lispro-aabc (Lyumjev – Lilly), a faster-acting formulation of insulin lispro (Humalog), for treatment of type 1 and type 2 diabetes in adults. Fiasp, a faster-acting formulation of insulin aspart (Novolog), was approved in 2017.